|1.||Cao, Jian: 5 articles (07/2015 - 12/2002)|
|2.||Annabi, Borhane: 5 articles (08/2011 - 01/2002)|
|3.||Chatterjee, Amitava: 4 articles (03/2010 - 01/2005)|
|4.||Gingras, D: 4 articles (10/2001 - 03/2000)|
|5.||Béliveau, R: 4 articles (10/2001 - 03/2000)|
|6.||Sato, H: 4 articles (09/2001 - 01/2000)|
|7.||Seiki, M: 4 articles (09/2001 - 01/2000)|
|8.||Okada, Y: 4 articles (03/2001 - 01/2000)|
|9.||Opdenakker, Ghislain: 3 articles (08/2014 - 12/2004)|
|10.||Temma, Takashi: 3 articles (10/2011 - 07/2009)|
03/01/2012 - "Moreover, mutant IDH2-induced HIF-1α improved the secretion levels of pro-MMP-2 and pro-MMP-9 as well as the conversion from pro-MMP-2 to its active form, giving C6 glioma cells a higher migration potential. "
05/15/2003 - "However, after coculture with the U251N glioma line, astrocyte pro-MMP-2 was converted to the active form. "
07/28/2009 - "Microglial MT1-MMP in turn activates glioma-derived pro-MMP-2 and promotes glioma expansion, as shown in an ex vivo model using MT1-MMP-deficient brain tissue and a microglia depletion paradigm. "
09/20/2000 - "Overexpression of a recombinant full-length MT1-MMP protein in glioma cells resulted in the activation of proMMP-2 that was correlated with the generation of the 43 kDa fragment of the protein. "
01/01/2000 - "SDS-PAGE zymography and Western blotting revealed that the expression of proMMP-2 in rat brains with C6 glioma cells was significantly higher than that in normal or the sham-operated rat brains, and that the activated form of MMP-2 was detected only in the former but not in the latter. "
01/01/2008 - "Plasma levels of proMMP-2 and MMP-2-TIMP-2 complex as well as the proMMP-2/TIMP-2 ratio were significantly higher in patients with active lymphoma and those in remission when compared to healthy controls. "
01/01/2008 - "Moreover, plasma levels of MMP-2-TIMP-2 complex, proMMP-2, TIMP-2, and proMMP-2/TIMP-2 ratio are at abnormal level in patients with newly diagnosed lymphoma and those in remission when compared to healthy controls. "
|3.||Lung Diseases (Lung Disease)
04/01/2007 - "In this study, we demonstrate that MSeA suppresses pro-MMP-2 activation in a dose-dependent manner induced by 12-O-tetradecanoylphorbol-13-acetate (PMA), and further decreases the invasiveness of HT1080 tumor cells. "
09/01/2005 - "In the present study, we evaluated the effect of NaBu on pro-MMP-9 and pro-MMP-2 secretion in human Jurkat and HT1080 cells, and in 36 pediatric solid tumors. "
07/01/2015 - "In support of a critical relationship between these two genes, miR-181a-5p-mediated reduction of MMP-14 levels was sufficient to decrease cancer cell migration, invasion, and activation of pro-MMP-2. "
03/01/2014 - "Comparison of proMMP-2 and prognostic factors revealed a statistically significant correlation between proMMP-2 and age in patients with histologic grade I tumors. "
01/01/2012 - "Membrane type-1 matrix metalloproteinase (MT1-MMP) has been implicated in tumor invasion, as well as trafficking of normal hematopoietic cells, and acts as a physiologic activator of proMMP-2. "
|1.||Tissue Inhibitor of Metalloproteinases (TIMP)
|2.||Tissue Inhibitor of Metalloproteinase-2
|3.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|4.||Phosphodiesterase 4 Inhibitors
|6.||Matrix Metalloproteinase 14 (MT1-MMP)
|7.||pro-matrix metalloproteinase 9
|9.||Matrix Metalloproteinase 2 (Gelatinase A)
|2.||Renal Dialysis (Hemodialysis)